2026-05-27

Coffee volume spike - 3.3× the 20-day average (10,798 vs 3,302 avg)

Cocoa volume spike - 2.8× the 20-day average (19,030 vs 6,856 avg)

Natural Gas bull 6.4% vs prior close ($2.89 → $3.08)

Gold volume spike - 3.1× the 20-day average (1,187 vs 387 avg)

OSINT: ECB warns Trump could spark financial crisis

Oil -4.78% - significant selloff

NATURAL GAS - speculators net long (+2.9σ vs 52w mean) - contrarian bear signal

OSINT: S&P 500 Futures Hit Record High, Up 19.7% Since March 30 Bottom

Saudi Arabia (Dhahran): drought conditions detected - potential oil supply impact

Oil -3.56% - significant selloff

OSINT: New Black Sea Resort Construction Launched by Alean, Cosmos, Azimut, Domina

OSINT: US College Grads Face 42.5% Underemployment, Worst Entry Market Since Pandemic

RBOB Gasoline bear 4.3% vs prior close ($3.22 → $3.08)

WTI Crude Oil bear 4.7% vs prior close ($93.89 → $89.48)

Wheat volume spike - 2.0× the 20-day average (69,341 vs 34,097 avg)

Heating Oil bear 4.7% vs prior close ($3.71 → $3.54)

GOLD RSI 24.2 - oversold (crossed below 30)

COPPER - speculators net long (+2.4σ vs 52w mean) - contrarian bear signal

Gold -1.24% - significant selloff

GOLD RSI 23.5 - oversold (crossed below 30)

BTC ETF inflow of $168M - institutional buying

BTC ETF inflow of $168M - institutional buying

BTC ETF inflow of $168M - institutional buying

FDA approves drug (ABBOTT) - new revenue stream

FDA approves drug (ABBOTT) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves NURTEC ODT (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves NURTEC ODT (PFIZER) - new revenue stream

FDA approves CORVERT (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves CORVERT (PFIZER) - new revenue stream

FDA approves NURTEC ODT (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves CORVERT (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

Q2-2025: Beat consensus by 40.6% - EPS $-0.03 vs $-0.0505 estimate

Q3-2025: Beat consensus by 15.4% - EPS $1.96 vs $1.6984 estimate

Q2-2025: Beat consensus by 20.7% - EPS $1.84 vs $1.5247 estimate

Q4-2025: Beat consensus by 10.2% - EPS $2.04 vs $1.8506 estimate

Q1-2026: Beat consensus by 25.8% - EPS $2.13 vs $1.6935 estimate

Q4-2025: Beat consensus by 23.7% - EPS $0.67 vs $0.5417 estimate

Q1-2026: Beat consensus by 5.1% - EPS $-0.11 vs $-0.1159 estimate

Q1-2026: Beat consensus by 19.8% - EPS $0.44 vs $0.3672 estimate

Q3-2025: Missed consensus by 156.0% - EPS $-0.08 vs $0.1428 estimate

Q3-2025: Beat consensus by 341.2% - EPS $0.63 vs $0.1428 estimate

Q4-2025: Beat consensus by 126.6% - EPS $1.01 vs $0.4457 estimate

Beat consensus by 67.9% - EPS $-10.24 vs $-31.875 estimate

Beat consensus by 40.9% - EPS $1.21 vs $0.8585 estimate

Q1-2011: Beat consensus by 35.9% - EPS $0.08986 vs $0.0661 estimate

Q1-2026: Missed consensus by 163.2% - EPS $-0.51 vs $-0.1938 estimate

Missed consensus by 17.6% - EPS $-0.16 vs $-0.136 estimate

Q4-2026: Beat consensus by 11.6% - EPS $0.68 vs $0.6094 estimate

Q1-2026: Missed consensus by 256.3% - EPS $-0.3 vs $-0.0842 estimate

Q3-2026: Beat consensus by 59.9% - EPS $0.57 vs $0.3564 estimate

Q2-2026: Missed consensus by 16.0% - EPS $1.2 vs $1.4289 estimate

Q2-2001: Missed consensus by 5.6% - EPS $0.17 vs $0.1801 estimate

Missed consensus by 23.3% - EPS $-0.28 vs $-0.227 estimate

Q1-2026: Missed consensus by 23.2% - EPS $-0.31 vs $-0.2516 estimate

Q1-2027: Beat consensus by 14.5% - EPS $2.02 vs $1.7647 estimate

Q4-2026: Missed consensus by 64.6% - EPS $-0.58 vs $-0.3523 estimate

Q4-2026: Beat consensus by 112.5% - EPS $0.02 vs $-0.1604 estimate

Q4-2025: Missed consensus by 29.2% - EPS $0.518 vs $0.7313 estimate

Q4-2024: Missed consensus by 24.6% - EPS $0.458 vs $0.6077 estimate

Q2-2024: Missed consensus by 6.7% - EPS $0.438 vs $0.4697 estimate

Q2-2025: Beat consensus by 31.2% - EPS $-0.11 vs $-0.1598 estimate

Q3-2025: Beat consensus by 27.8% - EPS $-0.14 vs $-0.1938 estimate

Q1-2026: Beat consensus by 16.6% - EPS $-0.27 vs $-0.3236 estimate

Q1-2026: Beat consensus by 21.2% - EPS $-39 vs $-49.5042 estimate

Q2-2025: Missed consensus by 515.5% - EPS $-111 vs $26.7138 estimate

Q4-2024: Beat consensus by 23.0% - EPS $38 vs $30.9035 estimate

Q3-2025: Missed consensus by 526.6% - EPS $-85 vs $19.9257 estimate

Beat consensus by 56.9% - EPS $0.16 vs $0.102 estimate

Q3-2025: Beat consensus by 13.7% - EPS $-2.19 vs $-2.5364 estimate

Q4-2025: Beat consensus by 62.3% - EPS $0.16 vs $0.0986 estimate

Missed consensus by 79.2% - EPS $-13.25 vs $-7.395 estimate

Missed consensus by 102.3% - EPS $-57.25 vs $-28.305 estimate

Beat consensus by 52.9% - EPS $-9.25 vs $-19.635 estimate

Missed consensus by 15.1% - EPS $-42.25 vs $-36.72 estimate

Q4-2025: Beat consensus by 181.6% - EPS $0.05 vs $-0.0613 estimate

Q2-2026: Missed consensus by 46.3% - EPS $-0.09 vs $-0.0615 estimate

Q3-2026: Missed consensus by 21.3% - EPS $0.06 vs $0.0762 estimate

Beat consensus by 71.7% - EPS $-6 vs $-21.21 estimate

Q3-2026: Beat consensus by 70.5% - EPS $-0.37 vs $-1.2558 estimate

Q2-2026: Missed consensus by 20.3% - EPS $-2.86 vs $-2.3769 estimate

Q1-2021: Missed consensus by 161.0% - EPS $-36 vs $58.9866 estimate

Q2-2021: Beat consensus by 550.3% - EPS $238 vs $36.5976 estimate

Q3-2021: Missed consensus by 114.2% - EPS $-34 vs $-15.8712 estimate

Q4-2020: Missed consensus by 6408.3% - EPS $-98 vs $1.5535 estimate

Q4-2025: Beat consensus by 110.3% - EPS $0.11 vs $0.0523 estimate

Q4-2025: Beat consensus by 51.8% - EPS $-2.03 vs $-4.2126 estimate

Q1-2026: Beat consensus by 7.5% - EPS $-3.09 vs $-3.3422 estimate

Q3-2025: Missed consensus by 1108.4% - EPS $-5.3 vs $-0.4386 estimate

Q2-2025: Beat consensus by 15.7% - EPS $-5.38 vs $-6.3852 estimate

Q1-2026: Beat consensus by 109.2% - EPS $0.05 vs $-0.5435 estimate

Q4-2025: Missed consensus by 38.5% - EPS $-0.69 vs $-0.4983 estimate

Beat consensus by 6.8% - EPS $-0.55 vs $-0.59 estimate

Q1-2026: Beat consensus by 41.2% - EPS $-0.06 vs $-0.1021 estimate

Q4-2025: Beat consensus by 82.2% - EPS $-0.02 vs $-0.1123 estimate

Q3-2025: Beat consensus by 114.3% - EPS $0.2 vs $-1.3954 estimate

Q2-2025: Beat consensus by 23.3% - EPS $-0.83 vs $-1.0826 estimate

Q1-2026: Beat consensus by 93.7% - EPS $-0.03 vs $-0.4799 estimate

Q1-2026: Missed consensus by 17.0% - EPS $-1.05 vs $-0.8976 estimate

Q4-2025: Missed consensus by 25.2% - EPS $-1.03725 vs $-0.8288 estimate

Beat consensus by 121.8% - EPS $0.5 vs $-2.295 estimate

Missed consensus by 96.1% - EPS $-1 vs $-0.51 estimate

Q1-2026: Beat consensus by 11.6% - EPS $0.11 vs $0.0986 estimate

Q4-2025: Beat consensus by 33.7% - EPS $0.15 vs $0.1122 estimate

Q2-2025: Beat consensus by 74.2% - EPS $0.12 vs $0.0689 estimate

Q3-2025: Beat consensus by 34.2% - EPS $0.13 vs $0.0969 estimate

Missed consensus by 154.9% - EPS $-0.26 vs $-0.102 estimate

Q1-2026: Beat consensus by 32.8% - EPS $-0.12 vs $-0.1785 estimate

Missed consensus by 22.5% - EPS $-0.25 vs $-0.204 estimate

Q2-2024: Beat consensus by 8.6% - EPS $0.256 vs $0.2357 estimate

Missed consensus by 366.2% - EPS $-32.1 vs $-6.885 estimate

Q2-2024: Beat consensus by 29.7% - EPS $-3.81 vs $-5.4162 estimate

Q4-2023: Missed consensus by 9.6% - EPS $-5.1 vs $-4.6512 estimate

Q3-2025: Beat consensus by 15.6% - EPS $-0.24 vs $-0.2842 estimate

Q1-2026: Missed consensus by 5.4% - EPS $-0.29 vs $-0.2751 estimate

Beat consensus by 13.0% - EPS $-0.26 vs $-0.299 estimate

Q2-2025: Beat consensus by 7.5% - EPS $-0.23 vs $-0.2486 estimate

Q1-2026: Beat consensus by 14.1% - EPS $0.79 vs $0.6924 estimate

Q3-2025: Beat consensus by 13.4% - EPS $0.86 vs $0.7585 estimate

Q4-2025: Missed consensus by 6.2% - EPS $0.75 vs $0.7996 estimate

Q4-2025: Missed consensus by 5.7% - EPS $1.02 vs $1.0812 estimate

Q1-2026: Missed consensus by 6.5% - EPS $1.29 vs $1.3804 estimate

Missed consensus by 15.5% - EPS $5.6 vs $6.63 estimate

Beat consensus by 6.6% - EPS $8.7 vs $8.16 estimate

Missed consensus by 13.5% - EPS $8.5 vs $9.826 estimate

Beat consensus by 26.1% - EPS $1.8 vs $1.428 estimate

Missed consensus by 45.5% - EPS $-2.3 vs $-1.581 estimate

Beat consensus by 48.8% - EPS $-0.6 vs $-1.173 estimate

Beat consensus by 31.4% - EPS $-1.4 vs $-2.04 estimate

Beat consensus by 9.1% - EPS $-1.9 vs $-2.091 estimate

Q1-2026: Missed consensus by 49.8% - EPS $-0.27 vs $-0.1802 estimate

Q1-2026: Beat consensus by 21.4% - EPS $0.23 vs $0.1894 estimate

Beat consensus by 481.8% - EPS $0.32 vs $0.055 estimate

Q4-2026: Beat consensus by 8.9% - EPS $1.71 vs $1.5703 estimate

Q4-2026: Missed consensus by 7.7% - EPS $0.32 vs $0.3468 estimate

Q1-2026: Beat consensus by 11.6% - EPS $0.42 vs $0.3764 estimate

Q2-2026: Beat consensus by 15.5% - EPS $0.37 vs $0.3203 estimate

Missed consensus by 31.8% - EPS $0.08 vs $0.1173 estimate

Q1-2026: Beat consensus by 236.1% - EPS $0.22 vs $-0.1616 estimate

Q1-2026: Missed consensus by 16092.7% - EPS $-1141 vs $7.1345 estimate

Q4-2025: Missed consensus by 15.4% - EPS $37.45996 vs $44.2832 estimate

Q4-2025: Missed consensus by 8.5% - EPS $1.8 vs $1.9663 estimate

Q3-2025: Beat consensus by 33.7% - EPS $2.26 vs $1.6898 estimate

Q1-2026: Beat consensus by 29.4% - EPS $1.81 vs $1.3984 estimate

Missed consensus by 37.3% - EPS $0.16 vs $0.255 estimate

Q2-2023: Beat consensus by 28.7% - EPS $0.105 vs $0.0816 estimate

Q3-2025: Missed consensus by 30.1% - EPS $-2.28 vs $-1.7524 estimate

Q1-2026: Missed consensus by 18.0% - EPS $-2.15 vs $-1.8227 estimate

Q2-2025: Beat consensus by 34.3% - EPS $-1.85 vs $-2.8162 estimate

Beat consensus by 37.4% - EPS $-20.7 vs $-33.048 estimate

Missed consensus by 29.5% - EPS $-7 vs $-5.406 estimate

Missed consensus by 157.6% - EPS $-13.4 vs $-5.202 estimate

Missed consensus by 61.1% - EPS $-14.3 vs $-8.874 estimate

Q4-2025: Beat consensus by 10.6% - EPS $0.64 vs $0.5786 estimate

Q3-2025: Missed consensus by 298.1% - EPS $-1.43 vs $0.7219 estimate

Q1-2026: Beat consensus by 177.2% - EPS $0.29 vs $0.1046 estimate

Q2-2025: Missed consensus by 93.3% - EPS $0.02 vs $0.3005 estimate

Beat consensus by 32.5% - EPS $-1.24 vs $-1.836 estimate

Q3-2025: Beat consensus by 32.2% - EPS $-0.85 vs $-1.2546 estimate

Beat consensus by 28.5% - EPS $-0.45 vs $-0.629 estimate

Q1-2026: Beat consensus by 63.1% - EPS $-0.26 vs $-0.7038 estimate

Q1-2026: Missed consensus by 58.2% - EPS $0.13 vs $0.3111 estimate

Q4-2025: Missed consensus by 17.1% - EPS $0.4 vs $0.4825 estimate

Q3-2025: Missed consensus by 30.3% - EPS $0.38 vs $0.5453 estimate

Q4-2026: Missed consensus by 19.1% - EPS $-0.73 vs $-0.6129 estimate

Q1-2026: Missed consensus by 8.0% - EPS $-0.71 vs $-0.6574 estimate

Q3-2026: Beat consensus by 16.3% - EPS $-0.61 vs $-0.7285 estimate

Missed consensus by 18.8% - EPS $-2 vs $-1.683 estimate

Q3-2025: Beat consensus by 23.9% - EPS $-1.3 vs $-1.7085 estimate

Q4-2025: Beat consensus by 27.1% - EPS $-0.7 vs $-0.9601 estimate

Q1-2026: Missed consensus by 16.0% - EPS $-1.08 vs $-0.9308 estimate

Q2-2025: Missed consensus by 77.7% - EPS $-0.58 vs $-0.3264 estimate

Q4-2025: Beat consensus by 24.4% - EPS $-0.29 vs $-0.3838 estimate

Q3-2025: Missed consensus by 5.6% - EPS $-0.42 vs $-0.3978 estimate

Q1-2026: Beat consensus by 56.4% - EPS $-0.1 vs $-0.2295 estimate

Q2-2025: Beat consensus by 5.5% - EPS $-0.4 vs $-0.4233 estimate

Beat consensus by 18.3% - EPS $-0.21 vs $-0.257 estimate

Q4-2025: Beat consensus by 43.7% - EPS $-0.18 vs $-0.3196 estimate

Q1-2026: Beat consensus by 64.4% - EPS $0.57 vs $0.3468 estimate

Q3-2025: Missed consensus by 47.1% - EPS $-0.09 vs $-0.0612 estimate

Beat consensus by 31.4% - EPS $-0.07 vs $-0.102 estimate

Beat consensus by 70.6% - EPS $-0.03 vs $-0.102 estimate

Beat consensus by 13.9% - EPS $-2.02 vs $-2.346 estimate

Missed consensus by 158.8% - EPS $-1.08 vs $1.836 estimate

Q4-2025: Missed consensus by 272.3% - EPS $-3.19 vs $-0.8568 estimate

Q1-2026: Beat consensus by 182.4% - EPS $0.37 vs $-0.4488 estimate

Missed consensus by 1126.1% - EPS $-150.07 vs $-12.24 estimate

Missed consensus by 87.2% - EPS $-25.2 vs $-13.464 estimate

Missed consensus by 71.6% - EPS $-10458 vs $-6095.52 estimate

Fed net liquidity surged $207bn in 4 weeks - significant injection, risk-on tailwind

china_us_west shipping +9.8% - potential inflation signal

china_us_west shipping +9.8% - potential inflation signal